Addition of an arterio-venous shunt during veno-arterial extracorporeal life support in a patient with Hantavirus pulmonary syndrome;Adición de un cortocircuito arterio-venoso durante el soporte vital extracorpóreo veno-arterial de un paciente con síndrome cardiopulmonar por Hantavirus. Caso clínico

Revista Medica de Chile

Volumn 133, Issue 7, 2005, Pages 817-822

  Tomicic F, Vinko ^a,b   Espinoza R, Mauricio ^a   Torres M, Javier ^a   Abarca Z, Juan ^a   Montes S, José Miguel ^a   Luppi N, Mario ^a   Concha F, Andrés ^a   Reynolds H, Enrique ^a   Laporte M, Alberto ^a   Canals L, Claudio ^a   Vial C, Pablo ^a  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b NONE   (Chile)

Author keywords

Extracorporeal circulation; Hantavirus; Hantavirus pulmonary syndrome

Indexed keywords

ADULT; ARTERIOVENOUS SHUNT; ARTICLE; CASE REPORT; EXTRACORPOREAL OXYGENATION; HANTAVIRUS PULMONARY SYNDROME; HUMAN; INSTRUMENTATION; MALE; METHODOLOGY; PULMONARY ARTERY;

ADULT; ARTERIOVENOUS SHUNT, SURGICAL; EXTRACORPOREAL MEMBRANE OXYGENATION; HANTAVIRUS PULMONARY SYNDROME; HUMANS; MALE; PULMONARY ARTERY;

EID: 27744535142     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. LEWANDOWSKY K, LOHBRUNNER H, LEWANDOWSKY M, FALKE K. Outcome and follow-up of adults following extracorporeal life support. En Zwischenberger J, Steinhorn R Bartlett R, ed. Extracorporeal cardiopulmonary support in critical care. Second Edition: Editorial Extracorporeal Life Support Organization, 2000; 531-62.
2. MOULTON S, DELIUS R, ARENSMAN R. Vascular access for extracorporeal life support. En Arensman R, Cornish J, ed. Extracorporeal life support. Editorial Blackwell Scientific Publications. 1993; 175-94.
3. CASTILLO C, NARANJO J, SEPÚLVEDA A, OSSA G, LEVY H. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile. Clinical experience with 16 adults. Chest 2001; 120: 548-54.
4. HALLIN G, SIMPSON S, CROWELL R, JAMES DS, KOSTER FT, MERTZ GJ ET AL. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996; 24: 252-8.
5. DUCHIN JS, KOSTER FT, PETERS CJ, SIMPSON GL, TEMPEST B, KAKI SR ET AL. Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease. NEJM 1994; 330: 949-55.
6. CROWLEY M, KATZ RW, KESSLER R, SIMPSON SQ, LEVY H, HALLIN GW ET AL. Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 1998; 26: 409-14.
7. DALTON HJ. Extracorporeal life support in the new millennium: Forging ahead or fading out? New Horiz 1999; 7: 414-32.
8. HILL JD, RATLIFF JL, FALLAT RJ, TUCKER HJ, LAMY M, DIETRICH H-P ET AL. Prognostic factors in the treatment of acute respiratory insufficiency with long-term extracorporeal oxygenation. J Thoracic Cardiovascular Surgery 1974; 68: 905-17.
9. KNAUS W, DRAPER E, WAGNER D, ZIMMERMAN J. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
10. TOMICIC V, ESPINOZA M, HERNÁNDEZ G, ABARCA L. Monitoreo de la volemia y el agua pulmonar extravascular en UCI. Medicina Intensiva 2002; 17: 15-9.
11. ROMERO C, ANDRESEN M, DÍAZ O, TOMICIC V, BARAHONA F, MERCADO M ET AL. Síndrome cardiopulmonar por Hantavirus: utilidad de la monitorización con el sistema PiCCO. Rev Méd Chile 2003; 131: 1173-8.
12. TOMICIC V, ANDRESEN M, ROMERO C, MERCADO M. Impacto hemodinánico de la presión positiva de fin de espiración (PEEP) durante la falla respiratoria grave: visión actual. Rev Méd Chile 2002; 130: 1419-30.
13. Applications and management of ECMO. En Meyer D, Jessen M, ed. Extracorporeal life support. Editorial Landes Bioscience, 2001; 84-97.
14. KOLLA S, AWAD S, RICH P, SCHREINER R, HIRSCHL R, BARTLETT R. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg 1997; 226: 544-66.
15. TOMICIC V, CASTILLO L. Soporte extracorpóreo con membrana de oxigenación (ECMO). En Vial PA, Valdivieso F, Ferrés M, ed. Manejo del paciente crítico con síndrome cardiopulmonar por hantavirus. Primera Edición: Editorial Salesianos S.A., 2004; 75-83.
16. CASTILLO L, VELASCO S, IRARRÁZABAL MJ, GARAYAR B, HERNÁNDEZ G, CÓRDOVA S ET AL. Falla cardiorrespiratoria severa tratada con asistencia cardiopulmonar extracorpórea. Caso Clínico. Rev Méd Chile 2002; 130: 545-50.
17. HINES M, FAUZA D, WILSON J. ECMO: Hemodynamics, perfusion and blood volume. En Zwischenberger J, Steinhorn R Bartlett R, ed. Extracorporeal cardiopulmonary support in critical care. Second Edition: Editorial Extracorporeal Life Support Organization, 2000; 97-112.
18. LYNCH JP, MHYRE JG, DANTZKER DR. Influence of cardiac output on intrapulmonary shunt. J Appl Physiol 1979; 46: 315-21.
19. PRANIKOFF T, HIRSCHL R, STEIMLE C, ANDERSON H, BARTLETT R. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med 1997; 25: 28-32.
20. http://epi.minsal.cl/epi/html/frames/frame2.htm
21. SERNA D, BRENNER M, CHEN JC. Severe hantavirus pulmonary syndrome: A new indication for extracorporeal life support? Crit Care Med 1998; 26: 217-8.